Skip to Content

Virtus LifeSci Biotech Clinical Trls ETF BBC

Medalist Rating as of | See Virtus Investment Hub

Morningstar’s Analysis BBC

Will BBC outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Weakness in Virtus LifeSci Biotech Clinical Trls ETF's Process and People Pillar ratings limits this strategy to a Morningstar Medalist Rating of Negative.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The strategy charges fees in line with its similarly distributed peers, priced within the middle quintile.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings BBC

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 11.7
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Bny Mellon Cash Reserve Usd

1.87 214,591
Cash and Equivalents

Morphic Holding Inc

1.59 181,954
Healthcare

Longboard Pharmaceuticals Inc

1.46 167,135
Healthcare

uniQure NV

1.31 150,359
Healthcare

Nurix Therapeutics Inc Ordinary Shares

1.13 128,890
Healthcare

Erasca Inc

1.08 123,332
Healthcare

ORIC Pharmaceuticals Inc

1.04 118,577
Healthcare

Acelyrin Inc

1.03 118,349
Healthcare

Praxis Precision Medicines Inc Ordinary Shares

1.00 114,989
Healthcare

Edgewise Therapeutics Inc

0.99 113,311
Healthcare